#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Microbiota Mediates Pathogen Clearance from the Gut Lumen after Non-Typhoidal Diarrhea


Many enteropathogenic bacteria target the mammalian gut. The mechanisms protecting the host from infection are poorly understood. We have studied the protective functions of secretory antibodies (sIgA) and the microbiota, using a mouse model for S. typhimurium diarrhea. This pathogen is a common cause of diarrhea in humans world-wide. S. typhimurium (S. tmatt, sseD) causes a self-limiting gut infection in streptomycin-treated mice. After 40 days, all animals had overcome the disease, developed a sIgA response, and most had cleared the pathogen from the gut lumen. sIgA limited pathogen access to the mucosal surface and protected from gut inflammation in challenge infections. This protection was O-antigen specific, as demonstrated with pathogens lacking the S. typhimurium O-antigen (wbaP, S. enteritidis) and sIgA-deficient mice (TCRβ−/−δ−/−, JH−/−, IgA−/−, pIgR−/−). Surprisingly, sIgA-deficiency did not affect the kinetics of pathogen clearance from the gut lumen. Instead, this was mediated by the microbiota. This was confirmed using ‘L-mice’ which harbor a low complexity gut flora, lack colonization resistance and develop a normal sIgA response, but fail to clear S. tmatt from the gut lumen. In these mice, pathogen clearance was achieved by transferring a normal complex microbiota. Thus, besides colonization resistance ( = pathogen blockage by an intact microbiota), the microbiota mediates a second, novel protective function, i.e. pathogen clearance. Here, the normal microbiota re-grows from a state of depletion and disturbed composition and gradually clears even very high pathogen loads from the gut lumen, a site inaccessible to most “classical” immune effector mechanisms. In conclusion, sIgA and microbiota serve complementary protective functions. The microbiota confers colonization resistance and mediates pathogen clearance in primary infections, while sIgA protects from disease if the host re-encounters the same pathogen. This has implications for curing S. typhimurium diarrhea and for preventing transmission.


Vyšlo v časopise: The Microbiota Mediates Pathogen Clearance from the Gut Lumen after Non-Typhoidal Diarrhea. PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001097
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001097

Souhrn

Many enteropathogenic bacteria target the mammalian gut. The mechanisms protecting the host from infection are poorly understood. We have studied the protective functions of secretory antibodies (sIgA) and the microbiota, using a mouse model for S. typhimurium diarrhea. This pathogen is a common cause of diarrhea in humans world-wide. S. typhimurium (S. tmatt, sseD) causes a self-limiting gut infection in streptomycin-treated mice. After 40 days, all animals had overcome the disease, developed a sIgA response, and most had cleared the pathogen from the gut lumen. sIgA limited pathogen access to the mucosal surface and protected from gut inflammation in challenge infections. This protection was O-antigen specific, as demonstrated with pathogens lacking the S. typhimurium O-antigen (wbaP, S. enteritidis) and sIgA-deficient mice (TCRβ−/−δ−/−, JH−/−, IgA−/−, pIgR−/−). Surprisingly, sIgA-deficiency did not affect the kinetics of pathogen clearance from the gut lumen. Instead, this was mediated by the microbiota. This was confirmed using ‘L-mice’ which harbor a low complexity gut flora, lack colonization resistance and develop a normal sIgA response, but fail to clear S. tmatt from the gut lumen. In these mice, pathogen clearance was achieved by transferring a normal complex microbiota. Thus, besides colonization resistance ( = pathogen blockage by an intact microbiota), the microbiota mediates a second, novel protective function, i.e. pathogen clearance. Here, the normal microbiota re-grows from a state of depletion and disturbed composition and gradually clears even very high pathogen loads from the gut lumen, a site inaccessible to most “classical” immune effector mechanisms. In conclusion, sIgA and microbiota serve complementary protective functions. The microbiota confers colonization resistance and mediates pathogen clearance in primary infections, while sIgA protects from disease if the host re-encounters the same pathogen. This has implications for curing S. typhimurium diarrhea and for preventing transmission.


Zdroje

1. BackhedF

LeyRE

SonnenburgJL

PetersonDA

GordonJI

2005 Host-bacterial mutualism in the human intestine. Science 307 1915 1920

2. IvanovII

AtarashiK

ManelN

BrodieEL

ShimaT

2009 Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139 485 498

3. van der WaaijD

Berghuis-de VriesJM

LekkerkerkL-v

1971 Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 69 405 411

4. VollaardEJ

ClasenerHA

1994 Colonization resistance. Antimicrob Agents Chemother 38 409 414

5. StecherB

HardtWD

2008 The role of microbiota in infectious disease. Trends Microbiol 16 107 114

6. BarthelM

HapfelmeierS

Quintanilla-MartinezL

KremerM

RohdeM

2003 Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71 2839 2858

7. BarmanM

UnoldD

ShifleyK

AmirE

HungK

2008 Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 76 907 915

8. HohmannEL

2001 Nontyphoidal salmonellosis. Clin Infect Dis 32 263 269

9. DethlefsenL

HuseS

SoginML

RelmanDA

2008 The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing. PLoS Biol 6 e280

10. DoreK

BuxtonJ

HenryB

PollariF

MiddletonD

2004 Risk factors for Salmonella typhimurium DT104 and non-DT104 infection: a Canadian multi-provincial case-control study. Epidemiol Infect 132 485 493

11. BuchwaldDS

BlaserMJ

1984 A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis 6 345 356

12. BalfourAE

LewisR

AhmedS

1999 Convalescent excretion of Salmonella enteritidis in infants. J Infect 38 24 25

13. GreigJD

ToddEC

BartlesonCA

MichaelsBS

2007 Outbreaks where food workers have been implicated in the spread of foodborne disease. Part 1. Description of the problem, methods, and agents involved. J Food Prot 70 1752 1761

14. BaderMW

SanowarS

DaleyME

SchneiderAR

ChoU

2005 Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122 461 472

15. GunnJS

LimKB

KruegerJ

KimK

GuoL

1998 PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 27 1171 1182

16. BrownA

HormaecheCE

1989 The antibody response to salmonellae in mice and humans studied by immunoblots and ELISA. Microb Pathog 6 445 454

17. MittruckerHW

RaupachB

KohlerA

KaufmannSH

2000 Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol 164 1648 1652

18. UrenTK

WijburgOL

SimmonsC

JohansenFE

BrandtzaegP

2005 Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies. Eur J Immunol 35 180 188

19. MaaserC

HousleyMP

IimuraM

SmithJR

VallanceBA

2004 Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun 72 3315 3324

20. StecherB

ChaffronS

KappeliR

HapfelmeierS

FreedrichS

2010 Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 6 e1000711

21. StecherB

RobbianiR

WalkerAW

WestendorfAM

BarthelM

2007 Salmonella enterica Serovar Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota. PLoS Biol 5 e244

22. HapfelmeierS

StecherB

BarthelM

KremerM

MüllerA

2005 The Salmonella Pathogenicity Island (SPI)-1 and SPI-2 Type III Secretion Systems Allow Salmonella Serovar Typhimurium to trigger Colitis via MyD88-Dependent and MyD88-Independent Mechanisms. J Immunol 174 1675 1685

23. CoombesBK

CoburnBA

PotterAA

GomisS

MirakhurK

2005 Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect Immun 73 7161 7169

24. HapfelmeierS

HardtWD

2005 A mouse model for S. typhimurium-induced enterocolitis. Trends Microbiol

25. CurtissR3rd

KellySM

HassanJO

1993 Live oral avirulent Salmonella vaccines. Vet Microbiol 37 397 405

26. SimonsenJ

MolbakK

FalkenhorstG

KrogfeltKA

LinnebergA

2009 Estimation of incidences of infectious diseases based on antibody measurements. Stat Med 28 1882 1895

27. AngelakopoulosH

HohmannEL

2000 Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 68 2135 2141

28. KangHY

SrinivasanJ

CurtissR3rd

2002 Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine. Infect Immun 70 1739 1749

29. BergmanMA

CummingsLA

BarrettSL

SmithKD

LaraJC

2005 CD4+ T cells and toll-like receptors recognize Salmonella antigens expressed in bacterial surface organelles. Infect Immun 73 1350 1356

30. SlackE

HapfelmeierS

StecherB

VelykoredkoY

StoelM

2009 Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325 617 620

31. MartinoliC

ChiavelliA

RescignoM

2007 Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity 27 975 984

32. WijburgOL

UrenTK

SimpfendorferK

JohansenFE

BrandtzaegP

2006 Innate secretory antibodies protect against natural Salmonella typhimurium infection. J Exp Med 203 21 26

33. MacphersonAJ

GattoD

SainsburyE

HarrimanGR

HengartnerH

2000 A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288 2222 2226

34. BrandtzaegP

2009 Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 70 505 515

35. SuarM

PeriaswamyB

SonghetP

MisselwitzB

MullerA

2009 Accelerated type III secretion system 2-dependent enteropathogenesis by a Salmonella enterica serovar enteritidis PT4/6 strain. Infect Immun 77 3569 3577

36. IlgK

EndtK

MisselwitzB

StecherB

AebiM

2009 O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice. Infect Immun 77 2568 2575

37. TurnbaughPJ

HamadyM

YatsunenkoT

CantarelBL

DuncanA

2008 A core gut microbiome in obese and lean twins. Nature

38. DuerkopBA

VaishnavaS

HooperLV

2009 Immune responses to the microbiota at the intestinal mucosal surface. Immunity 31 368 376

39. BohnhoffM

DrakeBL

MillerCP

1954 Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc Soc exp Biol, NY 86 132 137

40. TurnbaughPJ

HamadyM

YatsunenkoT

CantarelBL

DuncanA

2009 A core gut microbiome in obese and lean twins. Nature 457 480 484

41. HuseSM

DethlefsenL

HuberJA

WelchDM

RelmanDA

2008 Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet 4 e1000255

42. Sarma-RupavtarmRB

GeZ

SchauerDB

FoxJG

PolzMF

2004 Spatial distribution and stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tract. Appl Environ Microbiol 70 2791 2800

43. LeyRE

HamadyM

LozuponeC

TurnbaughPJ

RameyRR

2008 Evolution of mammals and their gut microbes. Science 320 1647 1651

44. NardiRM

SilvaME

VieiraEC

BambirraEA

NicoliJR

1989 Intragastric infection of germfree and conventional mice with Salmonella typhimurium. Braz J Med Biol Res 22 1389 1392

45. RawlsJ

2007 Enteric infection and inflammation alter gut microbial ecology. Cell host and microbe 2 73 74

46. Gaboriau-RouthiauV

RakotobeS

LecuyerE

MulderI

LanA

2009 The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31 677 689

47. MittruckerHW

KaufmannSH

2000 Immune response to infection with Salmonella typhimurium in mice. J Leukoc Biol 67 457 463

48. ChenJ

TrounstineM

AltFW

YoungF

KuraharaC

1993 Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol 5 647 656

49. HarrimanGR

BogueM

RogersP

FinegoldM

PachecoS

1999 Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J Immunol 162 2521 2529

50. UrenTK

JohansenFE

WijburgOL

KoentgenF

BrandtzaegP

2003 Role of the polymeric Ig receptor in mucosal B cell homeostasis. J Immunol 170 2531 2539

51. MombaertsP

MizoguchiE

LjunggrenHG

IacominiJ

IshikawaH

1994 Peripheral lymphoid development and function in TCR mutant mice. Int Immunol 6 1061 1070

52. StecherB

BarthelM

SchlumbergerMC

HaberliL

RabschW

2008 Motility allows S. Typhimurium to benefit from the mucosal defence. Cell Microbiol 10 1166 1180

53. HapfelmeierS

MullerAJ

StecherB

KaiserP

BarthelM

2008 Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. Typhimurium colitis. J Exp Med 205 437 450

54. StecherB

HapfelmeierS

MullerC

KremerM

StallmachT

2004 Flagella and Chemotaxis Are Required for Efficient Induction of Salmonella enterica Serovar Typhimurium Colitis in Streptomycin-Pretreated Mice. Infect Immun 72 4138 4150

55. MuellerC

2002 Tumour necrosis factor in mouse models of chronic intestinal inflammation. Immunology 105 1 8

56. EilebrechtS

PellayFX

OdenwalderP

BrysbaertG

BeneckeBJ

2008 EBER2 RNA-induced transcriptome changes identify cellular processes likely targeted during Epstein Barr Virus infection. BMC Res Notes 1 100

57. NothS

BrysbaertG

BeneckeA

2006 Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls. Genomics Proteomics Bioinformatics 4 90 109

58. KuninV

EngelbrektsonA

OchmanH

HugenholtzP

2009 Wrinkles in the rare biosphere: pyrosequencing errors lead to artificial inflation of diversity estimates. Environ Microbiol

59. DeSantisTZ

HugenholtzP

LarsenN

RojasM

BrodieEL

2006 Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72 5069 5072

60. EddySR

2002 A memory-efficient dynamic programming algorithm for optimal alignment of a sequence to an RNA secondary structure. BMC Bioinformatics 3 18

61. ColeJR

WangQ

CardenasE

FishJ

ChaiB

2009 The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37 D141 145

62. WangQ

GarrityGM

TiedjeJM

ColeJR

2007 Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73 5261 5267

63. SoginML

MorrisonHG

HuberJA

WelchDM

HuseSM

2006 Microbial diversity in the deep sea and the underexplored “rare biosphere”. Proc Natl Acad Sci U S A 103 12115 12120

64. QuinceC

LanzenA

CurtisTP

DavenportRJ

HallN

2009 Accurate determination of microbial diversity from 454 pyrosequencing data. Nat Methods 6 639 641

65. KanagawaT

2003 Bias and artifacts in multitemplate polymerase chain reactions (PCR). J Biosci Bioeng 96 317 323

66. JohansenFE

PeknaM

NorderhaugIN

HanebergB

HietalaMA

1999 Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med 190 915 922

67. JensenLJ

KuhnM

StarkM

ChaffronS

CreeveyC

2009 STRING 8–a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37 D412 416

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 9
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#